EW News and Press, Edwards Lifesciences Corporation From 10/25/23

Edwards Lifesciences Corporation (EW) is expected to report $0.59 for Q3 2023

2023-10-24 14:59:13 ET More on Edwards Lifesciences Edwards Lifesciences: Rising Dominance In Structural Heart Disease Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript Citi opens downside catalyst watch on Edwards ahead of Q3 earnings repor...

FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE PR Newswire SAN FRANCISCO , Oct. 24, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today announced new data from the PARTNER 3 trial demonstrat...

EDWARDS EVOQUE TRANSCATHETER TRICUSPID VALVE REPLACEMENT SYSTEM RECEIVES CE MARK PR Newswire IRVINE, Calif. , Oct. 19, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced the company's EVOQUE tricuspid valve replacement system receive...

2023-10-19 03:12:00 ET Summary Drugmakers don’t have to dominate a healthcare portfolio. Equity investors should cast a wide net across the sector to find innovation and growth. When pharmaceutical companies conduct tests on new drugs, they typically outsource clinical tria...

EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023 PR Newswire IRVINE, Calif. , Oct. 18, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended September 30, 2023 after the mar...

2023-10-14 05:20:00 ET Summary Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. Alphabet, Booking Holdings, and Texas Pacific Land were top contributors to portfolio performance d...

2023-10-06 12:15:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-10-02 15:46:04 ET More on Edwards Lifesciences Edwards Lifesciences: Rising Dominance In Structural Heart Disease Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript Edwards Lifesciences said to be the target of EU antitrust raid last wee...

2023-09-26 14:25:41 ET More on Edwards Lifesciences Seeking Alpha’s Quant Rating on Edwards Lifesciences Edwards Lifesciences: Rising Dominance In Structural Heart Disease Edwards Lifesciences Corporation (EW) Q2 2023 Earnings Call Transcript Edwa...